eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-INCY-Incyte Corp.

Incyte Corp. INCY

59.730.18(0.3%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Incyte Corp.
Today
Create an eToro account to buy INCY stock on a secure, user-friendly, multi-asset trading platform.
Buy Incyte Corp.
Buy Incyte Corp.
Incyte Corp. INCY
Buy INCY
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Sell
Price Target
59.67
Based on analysts who covered INCY

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Incyte Corp. News

INCY Stock Price Chart

‎4.77‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Incyte Corp. share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Incyte Corp. share price today is 59.73, reflecting a ‎0.3‎% change over the last 24 hours and ‎-3.65‎% over the past week. The current market capitalization of INCY is 11.56B with an average volume in the last three months of 2.1M. The stock has a P/E ratio of 184.81 and a dividend yield of 0%. With the stock’s beta sitting at 0.52
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
11.56B
Day’s Range
i
Shows the high and low prices of the day.
56.66 - 62.75
52W Range
i
Shows the high and low prices of the last year.
50.18 - 83.79
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.1M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
184.81
Revenue
i
The total income generated by this company’s goods and services last year.
4.41B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
59.73
EPS
i
A company’s total earnings divided by the number of shares it has issued.
0.32
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.52
What Is Incyte Corp.?
Incyte Corporation is an American multinational biopharmaceutical company with its headquarters in Wilmington, Delaware. The company was founded in 1991 and is primarily focused on the discovery, development and marketing of therapeutics for use in patients with serious unmet medical needs. The firm employs around 1,500 people worldwide, with facilities in the US, Canada, Europe and Japan.

The company operates in two main therapeutic areas. It has a focus on Haematology and Oncology, which is comprised of Myeloproliferative Neoplasms (MPNs) and Graft-Versus-Host Disease (GVHD) research, as well as addressing solid tumours and hematologic malignancies. The other therapeutic area of focus is Inflammation and Autoimmunity (IAI), which includes the firm’s dermatology commercial franchise.

The company’s main products in the area of oncology are Jakafi, Pemazyre and MONJUVI. In the area of dermatology, the firm produces Opzelura, a novel, prescription, inhibitor cream used for the treatment of chronic eczema. The company offers resources and support for patients via its website, including medical information, education and awareness materials. Incyte Corporation is listed on the NASDAQ where it trades under the stock ticker INCY.

You can easily monitor the INCY price chart for value changes by adding this stock to your eToro virtual portfolio today.
Buy INCY

How can I buy Incyte Corp. stocks?

To purchase Incyte Corp.:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Incyte Corp. (INCY) page and place an order to buy Incyte Corp..
Buy INCY
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Incyte Corp.
Invest in Incyte Corp.
Today
Create an eToro account to buy INCY stock on a secure, user-friendly, multi-asset trading platform.
Buy INCY

FAQ

The current price of INCY is 59.73.
The average price target for Incyte Corp. is 59.73. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Incyte Corp. based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Incyte Corp. is 11.56B
Based on 4 analysts offering recommendations for INCY in the last 3 months, the overall consensus is Moderate Sell.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top